drugset / Trial / NCT02574962
Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this pilot study is to assess the safety and efficacy of Acthar® Gel in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients.
Timeline
- Start
- 2015-08
- Primary completion
- 2018-07
- Completion
- 2018-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | repository corticotropin injection | Unknown | 1 ml | Subcutaneous |